- Advertisement -
Pfizer Inc’s experimental antiviral pill to treat COVID-19 cuts by 89 per cent the chances of hospitalisation or death for adults at risk of developing severe disease, the company says, offering what could be a promising new weapon in the fight against the pandemic.
The trial’s results…
